A5034487397- Endometriosis Research and Treatment
- Uterine Myomas and Treatments
- Ovarian cancer diagnosis and treatment
- Endometrial and Cervical Cancer Treatments
- Intraperitoneal and Appendiceal Malignancies
- Gynecological conditions and treatments
- Menstrual Health and Disorders
- Maternal and fetal healthcare
- Pelvic floor disorders treatments
- Pregnancy-related medical research
- Breast Lesions and Carcinomas
- Ovarian function and disorders
- Surgical Simulation and Training
- Breast Implant and Reconstruction
- Reproductive System and Pregnancy
- Breast Cancer Treatment Studies
- Gastric Cancer Management and Outcomes
- Renal and Vascular Pathologies
- Organ and Tissue Transplantation Research
- Abdominal vascular conditions and treatments
- Ectopic Pregnancy Diagnosis and Management
- Pregnancy and Medication Impact
- Electromagnetic Fields and Biological Effects
- Colorectal Cancer Surgical Treatments
- Pain Mechanisms and Treatments
Centre Hospitalier Intercommunal de Poissy
2021-2025
Centre Hospitalier Universitaire de Limoges
2018-2024
Centre de recherche en Epidémiologie et Santé des Populations
2016-2024
Inserm
2016-2024
Université Paris-Saclay
2020-2024
Université de Versailles Saint-Quentin-en-Yvelines
2020-2024
Université de Limoges
2019-2024
Risques cliniques et sécurité en santé des femmes et en santé périnatale
2023-2024
Hôpital Mère-Enfant
2018-2021
Centre Hospitalier Universitaire de Caen
2020
To compare survival and morbidity rates between primary cytoreductive surgery (pCRS) interval (iCRS) for epithelial ovarian cancer (EOC), using a propensity score. We conducted score-matched cohort study, data from the FRANCOGYN cohort. Retrospective, multicentre study of patients followed in 15 French department specialized treatment cancer. Patients included were those with International Federation Gynaecology Obstetrics (FIGO) stage III or IV EOC, peritoneal carcinomatosis, having...
International Federation of Gynecology and Obstetrics (FIGO) staging classification for stage IV epithelial ovarian cancer (EOC) separates stages IVA (pleural effusion) IVB (parenchymal and/or extra-abdominal lymph node metastases). We aimed to evaluate its prognostic impact compare survival according the initial metastatic location. conducted a multicenter study between 2000 2020, including patients with FIGO EOC. Primary endpoint was overall (OS). The secondary endpoints were...
18F-Fluorodeoxyglucose positron-emission tomography integrated with computed (18FDG PET-CT) is a non-invasive examination that could be helpful for the management of endometrial cancer. This study investigated performance 18FDG PET-CT in assessing para-aortic (PA) lymph-node involvement high-risk cancer.This was retrospective, single-center carried out between 2009 and 2018. The inclusion criteria were locally advanced type 1 or 2 cancer before PA lymphadenectomy.During period, among 142...
Dysmenorrhoea, dyspareunia, and non-menstrual chronic pelvic pain (NMCPP) are symptoms that probably underreported neglected. This study aimed to assess the prevalence overlapping relations between these among a general population of French women reproductive age. A cross-sectional nationwide CONSTANCES cohort recruiting representative sample within different areas was constructed. Women aged 18–49 years (n = 21,287) who reported periods in previous three months experienced intercourse at...
The objective of our study is to evaluate the diagnostic performance positron emission tomography/computed tomography (PET-CT) for assessment lymph node involvement in advanced epithelial ovarian, fallopian tubal or peritoneal cancer (EOC). This was a retrospective, bicentric study. We included all patients over 18 years age with histological diagnosis EOC who had undergone PET-CT at time prior cytoreduction surgery pelvic para-aortic lymphadenectomy. 145 primary EOC. calculated from data 63...
Labor is induced in over 20% of women France. Prostaglandins, especially intravaginal dinoprostone (Propess®), are widely used to initiate cervical ripening. If labor does not start within 24 h, there uncertainty about whether administer a second pessary or use oxytocin induce order achieve vaginal delivery.RE-DINO prospective, open-label, multicenter, randomized superiority trial with two parallel arms running six French hospitals. A total 360 patients ≥ 18 years age at > 37 weeks gestation...
Background: FDG-PET/CT is a noninvasive examination that could be helpful for the management of endometrial cancer. The aim this study was to evaluate performance in assessing para-aortic lymph-node involvement high-risk Methods: We performed retrospective multicenter including all patients who had cancer with preoperative and lymphadenectomy (PAL) between 2009 2019. main objective overall FDG-PET/CT. secondary objectives were its performances according histological type date (before or...